ArticleRSC advances2020

Elaborating piperazinyl-furopyrimidine based scaffolds as phosphoinositol-3-kinase enzyme alpha (PI3Kα) inhibitors to combat pancreatic cancer.

Mai A Mansour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.